Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dapagliflozin on Patients With Cardiomyopathy

NCT07076615 is registered in ClinicalTrials.gov with May Mohamed Abdalla as lead sponsor.

NCT NCT07076615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07076615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dapagliflozin on Patients With Cardiomyopathy
Lead sponsor
May Mohamed Abdalla
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2025
Completion date
May 31, 2026
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure (adhf)